[1]刘介眉 , 严庆汉 , 路英杰 , 等 病理组织染色的理论方法和应用[M ] 第 1版 北京∶人民卫生出版社 , 1983 10 8 10 9
|
[][2 ]IancuTC , DeugnierY , HallidayJW , etal MorphlogiccharacteristicsofHBVmarkersandproductsofironmetabolisminlivertissueinpa tientswithhepatitisBvirus[J] Vojnosanitpregl, 1992 , 49 (3 ) ∶477
|
[][3 ]IshidaM , NakagawaraG , ImanuraY , etal Ironandcopperdeposi tioninchronicactivehepatitisandlivercirrhosis∶pathogeneticroleinprogressivelivercelldamage[J] EurJHistochem , 1995 , 3 9 (3 ) ∶2 2 1
|
[4]CableEE , ConnorJR , Ison , etal Accumulationofironbyprimaryrathepatocytesinlong termculture∶changesinnuclearshapemediatedbyno transferrin boundformsofiron[J] AmJPathol, 1998, 15 2 (3 ) ∶781
|
[5 ]AkiyoshiF , StataM , UchimuraY , etal HepaticironstaingsinchronichepatitisCpatientswithlowHCVRNAlevels∶apredictivemarkerforIFNtherapy[J] AmJGastroenterol, 1997, 92 (9) ∶14 63
|
[6]OlynykJK , ReddyKR , Di BisceglieAM , etal Hepaticironconcen trationasapredictortointerferonalfatherapyinchronichepatitisC[J] Gastroenterology , 1995 , 10 8 (4) ∶110 4
|
[7]BartonALBannerBF , CableEE , etal DistributionofironintheliverpredictstheresponseofchronichepatitisCinfectiontointerferontherapy[J] AmJClinPathol, 1995 , 10 3 (4) ∶419
|
[8]BannerBF , BartonAL , CableEE , etal AdetailedanalysisoftheKn odellscoreandotherhistologicparametersaspredictorsofresponsetointerferontherapyinchronichepatitisC[J] ModPathol, 1995 , 8 (3 ) ∶2 3 2
|
[1] | Xu GUO, Hao WU. Research advances in the diagnosis and treatment of hepatic vein occlusion-type Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2024, 40(1): 13-18. doi: 10.12449/JCH240102 |
[2] | Jing YANG, Suxin LI, Yuehui ZHANG, Luhao LI, Zhaochen LIU, Dongqi SHEN, Xiaowei DANG. Effect of metformin on liver fibrosis in a mouse model of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2022, 38(9): 2034-2039. doi: 10.3969/j.issn.1001-5256.2022.09.017 |
[3] | Cui ZHOU, Bo SHEN, Ying QU, Lungen LU. Current status of the clinical management of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2022, 38(7): 1474-1476. doi: 10.3969/j.issn.1001-5256.2022.07.005 |
[4] | Pang RunHua, Zhu YaQing. Hepatic dysplastic nodules with Budd-Chiari syndrome misdiagnosed as hepatocellular carcinoma: A case report[J]. Journal of Clinical Hepatology, 2020, 36(5): 1115-1116. doi: 10.3969/j.issn.1001-5256.2020.05.033 |
[5] | Wang LiBo, Sun YuLing. Establishment of Budd-Chiari syndrome models and related research advances[J]. Journal of Clinical Hepatology, 2020, 36(4): 908-911. doi: 10.3969/j.issn.1001-5256.2020.04.044 |
[6] | Wu KaiMin, Cao Shan, Zhang GuoYan, Chen GuoDong, Su Lin, Wang ZhiFeng, Liu YuLan. A case of paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome as the first manifestation[J]. Journal of Clinical Hepatology, 2018, 34(10): 2197-2199. doi: 10.3969/j.issn.1001-5256.2018.10.028 |
[7] | Yu Hong, Sun DianXing, Liang ZhiHui, Li HaiJun, Yang XinYing, Kang FuBiao. Diagnosis and interventional therapy for Budd-Chiari syndrome secondary to hepatic venous obstruction[J]. Journal of Clinical Hepatology, 2017, 33(7): 1340-1341. doi: 10.3969/j.issn.1001-5256.2017.07.028 |
[8] | Zhang WenWen, Qi XingShun, Guo XiaoZhong. Significance of factor Ⅱ G20210A mutation in Budd-Chiari syndrome and portal vein thrombosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 310-314. doi: 10.3969/j.issn.1001-5256.2015.02.043 |
[9] | Hu FengRong, Gao Fan, Yang Qing, Qi XingShun. Significance of factor V Leiden mutation in Budd- Chiari syndrome and portal vein thrombosis[J]. Journal of Clinical Hepatology, 2014, 30(1): 86-89. doi: 10.3969/j.issn.1001-5256.2014.01.025 |
[10] | Xu Hao. Interventional therapy for intractable cases of Budd- Chiari syndrome[J]. Journal of Clinical Hepatology, 2013, 29(10): 748-751. doi: 10.3969/j.issn.1001-5256.2013.10.007 |
[11] | Xiao PeiRui, Lin XinYing, Guo ChengHao, Bian JianChao, Yang XiaoXia, Wang JinBiao. Study of correlation between the geographical distribution of Budd-Chiari syndrome with iodine content in drinking water[J]. Journal of Clinical Hepatology, 2011, 27(2): 130-133. |
[12] | Peng Tao, Zhang GuoYan, Liu YuLan. Identification of Budd-Chiari syndrome, hepatic sinusoidal obstruction syndrome and hepatic cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1022-1026+1031. |
[13] | Bian Ce, Wang ZhongHao, Li Zhen, Li ChunMin. Severe Budd-Chiari syndrome with 18 years patency after mesojugular shunt (case report)[J]. Journal of Clinical Hepatology, 2011, 27(2): 199-200. |
[14] | Meng QingYi, Sun NianFeng, Wang RuiHua, Liu ZhaoXuan, Li Bo, Wang ZhongHao. Interventional treatment for Budd-Chiari syndrome:reports of 883 cases[J]. Journal of Clinical Hepatology, 2011, 27(2): 127-129. |
[15] | Wang Kun, Yu ZhenHai, Li GuangXin, Zhang ShuGuang, Qin ShiYong, Wang MingHai, Ruan ZhangLe. The application of interventional therapy for Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2011, 27(2): 123-126. |
[16] | Wang ZhongHao, Li ChunMin, Li Zhen, Bian Ce, Gu YongQuan, Yu HengXi, Chen Bing. Evolution and prospects of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2011, 27(2): 113-115. |
[17] | Li ChunMin, Bian Ce, Wang ZhongHao. Spontanously healing of Budd-Chiari syndrome:a case report[J]. Journal of Clinical Hepatology, 2011, 27(2): 198+20. |